May 22, 2023 7:00 am EDT Immunovant Provides Corporate Updates and Reports Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2023
Feb 03, 2023 7:00 am EST Immunovant Reports Financial Results and Recent Business Updates for the Quarter Ended December 31, 2022
Nov 07, 2022 8:00 am EST Immunovant to Present at Guggenheim 4th Annual Immunology and Neurology Day on November 14th
Nov 04, 2022 7:00 am EDT Immunovant Reports Financial Results and Recent Business Updates for the Quarter Ended September 30, 2022
Oct 04, 2022 8:45 am EDT Immunovant Announces Pricing of $75.0 Million Underwritten Offering of Common Stock
Sep 09, 2022 8:00 am EDT Immunovant to Present at the H.C. Wainwright 24th Annual Global Investment Conference on September 14th
Aug 24, 2022 8:00 am EDT Immunovant to Host Investor Webcast to Announce Two New Indications for Batoclimab on September 7, 2022